Targeting aneuploidy for cancer therapy is an area of active research. Strategies include exploiting the vulnerabilities of aneuploid cells, such as their increased metabolic stress and reliance on certain cellular pathways. However, developing therapies that specifically target aneuploid cells without affecting normal cells remains a significant challenge.
